Shots: The approval of Minnebro (Esaxerenone) tablets (1.25/2.5/5 mg) is based on P-III ESAX-HTN study in patients with hypertension, with its regulatory approval submitted to MHLW in Feb’18 In Q2’19, […]readmore
Tags : Minnebro
Shots: The approval is based on P-III ESAX-HTN study assessing esaxerenone vs eplerenone for 12wks. in patients with essential hypertension, 1EP as SBP / DBP In 2006, Exelixis and Daiichi […]readmore